In this issue:
- The Mediterranean diet and MS risk
- Safety and efficacy of opicinumab in patients with relapsing MS
- Dysarthria in patients with MS
- Managing natalizumab treatment failure
- AI analysis of lesion dynamics and brain volume in patients with MS
- Natural history of MS in UK general practice
- Clinical outcomes and adherence to ofatumumab in the UK
- Cognitive impairment in older people with MS
- Are Fc gamma receptor polymorphisms biomarkers for therapeutic response in MS?
- Effects of caffeine supplementation on fatigue in MS
Please login below to download this issue (PDF)